Hangzhou Alltest Biotech Past Earnings Performance
Past criteria checks 1/6
Hangzhou Alltest Biotech's earnings have been declining at an average annual rate of -20.2%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 5% per year. Hangzhou Alltest Biotech's return on equity is 7.1%, and it has net margins of 34%.
Key information
-20.2%
Earnings growth rate
-24.4%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | -5.0% |
| Return on equity | 7.1% |
| Net Margin | 34.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Hangzhou Alltest Biotech (SHSE:688606) May Have Issues Allocating Its Capital
Nov 22
Revenues Not Telling The Story For Hangzhou Alltest Biotech Co., Ltd. (SHSE:688606) After Shares Rise 27%
Oct 01Lacklustre Performance Is Driving Hangzhou Alltest Biotech Co., Ltd.'s (SHSE:688606) Low P/E
Aug 01Here's What's Concerning About Hangzhou Alltest Biotech's (SHSE:688606) Returns On Capital
Jun 08There Are Some Holes In Hangzhou Alltest Biotech's (SHSE:688606) Solid Earnings Release
May 03Optimistic Investors Push Hangzhou Alltest Biotech Co., Ltd. (SHSE:688606) Shares Up 27% But Growth Is Lacking
Apr 25Revenue & Expenses Breakdown
How Hangzhou Alltest Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 813 | 277 | 139 | 103 |
| 30 Jun 24 | 763 | 233 | 142 | 104 |
| 31 Mar 24 | 718 | 185 | 140 | 108 |
| 31 Dec 23 | 755 | 181 | 147 | 121 |
| 30 Sep 23 | 938 | -74 | 142 | 138 |
| 30 Jun 23 | 1,053 | -47 | 164 | 173 |
| 31 Mar 23 | 1,526 | 176 | 212 | 197 |
| 31 Dec 22 | 3,389 | 1,185 | 236 | 207 |
| 30 Sep 22 | 3,887 | 1,644 | 234 | 189 |
| 30 Jun 22 | 3,961 | 1,742 | 197 | 157 |
| 31 Mar 22 | 3,684 | 1,665 | 138 | 124 |
| 31 Dec 21 | 1,873 | 766 | 87 | 95 |
| 30 Sep 21 | 1,522 | 784 | 83 | 87 |
| 30 Jun 21 | 1,284 | 690 | 74 | 69 |
| 31 Mar 21 | 1,356 | 797 | 73 | 64 |
| 31 Dec 20 | 1,136 | 679 | 63 | 55 |
| 31 Dec 19 | 241 | 78 | 35 | 36 |
| 31 Dec 18 | 184 | 56 | 20 | 31 |
| 31 Dec 17 | 130 | 34 | 17 | 26 |
| 31 Dec 16 | 76 | 15 | 9 | 20 |
Quality Earnings: 688606 has a high level of non-cash earnings.
Growing Profit Margin: 688606 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688606's earnings have declined by 20.2% per year over the past 5 years.
Accelerating Growth: 688606 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 688606 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).
Return on Equity
High ROE: 688606's Return on Equity (7.1%) is considered low.